These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 7352386)

  • 21. Vasodilators for chronic congestive heart failure.
    Med Lett Drugs Ther; 1984 Dec; 26(677):115-6. PubMed ID: 6390110
    [No Abstract]   [Full Text] [Related]  

  • 22. Afterload reduction in the management of congestive heart failure following acute myocardial infarction.
    Miller RR; Awan NA; Mason DT
    Adv Cardiol; 1978; 23():173-81. PubMed ID: 345758
    [No Abstract]   [Full Text] [Related]  

  • 23. Vasodilators in the treatment of congestive heart failure.
    Ciafone RA
    Conn Med; 1983 Oct; 47(10):614-8. PubMed ID: 6414758
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular clinical pharmacology of impedance reducing agents.
    Franciosa JA; Pierpont G
    J Chronic Dis; 1981; 34(7):341-52. PubMed ID: 6788789
    [No Abstract]   [Full Text] [Related]  

  • 26. [Vasodilator therapy in management of chronic heart failure (author's transl)].
    Letac B; Champoud O; Moore N
    Therapie; 1981; 36(1):1-10. PubMed ID: 7015550
    [No Abstract]   [Full Text] [Related]  

  • 27. Afterload reduction in congestive heart failure.
    Miller RR; Awan N; Amsterdam EA; Mason DT
    Adv Cardiol; 1978; (22):199-204. PubMed ID: 413334
    [No Abstract]   [Full Text] [Related]  

  • 28. [The use of vasodilator agents in the therapy of chronic cardiac insufficiency].
    Koller H; Prager H
    Wien Med Wochenschr; 1982 Oct; 132(19):465-70. PubMed ID: 6129750
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of cardiac insufficiency with systemic vasodilator agents].
    García Puig J; Gil Aguado A; Arnalich F; Gaspar G; Anciones B; Vázquez JJ
    Med Clin (Barc); 1980 Nov; 75(9):398-403. PubMed ID: 7464335
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic principles of drug-induced cardiac debit with vasodilators].
    Urbaszek W; Modersohn D
    Z Gesamte Inn Med; 1980 Mar; 35(6):241-6. PubMed ID: 6105747
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The longer term efficacy of vasodilators in heart failure.
    Hernandez J; Owens CW
    Clin Ther; 1982; 5(2):142-54. PubMed ID: 7159899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vasodilator and inotropic therapy of heart failure [panel discussion].
    Am J Med; 1978 Jul; 65(1):208-16. PubMed ID: 685996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vasodilator agents in the treatment of cardiac insufficiency].
    Bertel O
    Ther Umsch; 1984 Feb; 41(2):117-24. PubMed ID: 6424258
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of a sodium nitroprusside-dobutamine combination in left cardiac failure].
    Moore N; Champoud O; Berland J; Cribier A; Letac B
    Therapie; 1985; 40(2):99-103. PubMed ID: 4002197
    [No Abstract]   [Full Text] [Related]  

  • 35. Preload and afterload without anguish: a simplified framework.
    Mandell HN; Deglin SM
    Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasodilators in the management of acute heart failure.
    Elkayam U; Janmohamed M; Habib M; Hatamizadeh P
    Crit Care Med; 2008 Jan; 36(1 Suppl):S95-105. PubMed ID: 18158484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Significance of nitrates in acute therapy of heart failure with and without lung edema].
    Beck OA
    Z Kardiol; 1985; 74 Suppl 1():15-22. PubMed ID: 3922141
    [No Abstract]   [Full Text] [Related]  

  • 38. [Special place of PETN among nitrates. No tolerance development, fewer headaches].
    Münzel T
    MMW Fortschr Med; 2008 Jan; 150(1-2):41. PubMed ID: 18300643
    [No Abstract]   [Full Text] [Related]  

  • 39. Vasodilator therapy.
    Sutton FJ
    Am J Med; 1986 Feb; 80(2B):54-8. PubMed ID: 3511697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sodium nitroprusside for advanced low-output heart failure.
    Mullens W; Abrahams Z; Francis GS; Skouri HN; Starling RC; Young JB; Taylor DO; Tang WH
    J Am Coll Cardiol; 2008 Jul; 52(3):200-7. PubMed ID: 18617068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.